Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Inhibitors of the enzyme UDP-glucose: N-acyl-sphingosine glucosyltransferase

Inhibitors of the enzyme UDP-glucose: N-acyl-sphingosine glucosyltransferase

US Patent 10385042 · Granted Aug 20, 2019

Estimated economic value: $3,414,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Deuterated OTX-0152020
Substituted triazolobenzodiazepines2019
Substituted xanthine derivatives2019
Substituted triazolobenzodiazepines2018
Deuterated pyrazino[2,1-a]isoquinoline compounds and methods of treatment using 2018
Substituted xanthine derivatives2018
Inhibitors of the enzyme UDP-glucose: N-acyl-sphingosine glucosyltransferase2017
Substituted triazolobenzodiazepines2017
Substituted thienotriazolodiazapines2017
Substituted xanthine derivatives2016
Substituted xanthine derivatives2016
Synthesis of deuterated morpholine derivatives2016